Elsa M. Cora

711 total citations
15 papers, 599 citations indexed

About

Elsa M. Cora is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Elsa M. Cora has authored 15 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Elsa M. Cora's work include HER2/EGFR in Cancer Research (10 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Toxin Mechanisms and Immunotoxins (3 papers). Elsa M. Cora is often cited by papers focused on HER2/EGFR in Cancer Research (10 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Toxin Mechanisms and Immunotoxins (3 papers). Elsa M. Cora collaborates with scholars based in United States, Puerto Rico and Brazil. Elsa M. Cora's co-authors include S F Little, S H Leppla, Nita J. Maihle, Andre T. Baron, Jacqueline M. Lafky, Karl C. Podratz, Cecelia H. Boardman, Marianela Pérez-Torres, René Nieves-Alicea and Trace Christensen and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Biochemistry and Cancer Research.

In The Last Decade

Elsa M. Cora

15 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elsa M. Cora United States	9	330	261	143	139	100	15	599
Abdellah Belmaaza Canada	16	669 2.0×	205 0.8×	153 1.1×	76 0.5×	187 1.9×	26	886
Ramziya Kiyamova Russia	13	269 0.8×	97 0.4×	73 0.5×	119 0.9×	64 0.6×	49	527
M J Ligtenberg Netherlands	8	574 1.7×	204 0.8×	153 1.1×	53 0.4×	124 1.2×	13	870
Patricia E. Murtha United States	13	586 1.8×	107 0.4×	342 2.4×	201 1.4×	50 0.5×	13	1.0k
T L Timme United States	16	530 1.6×	241 0.9×	239 1.7×	226 1.6×	166 1.7×	23	899
Warren Hurlburt United States	15	393 1.2×	234 0.9×	148 1.0×	125 0.9×	140 1.4×	19	1.0k
B Endlich United States	12	642 1.9×	262 1.0×	131 0.9×	92 0.7×	122 1.2×	18	887
B Fagg Switzerland	15	319 1.0×	167 0.6×	222 1.6×	112 0.8×	44 0.4×	25	871
Zhilan Zeng United States	8	306 0.9×	127 0.5×	129 0.9×	23 0.2×	82 0.8×	10	508
Hazel M. Weir United Kingdom	14	390 1.2×	394 1.5×	326 2.3×	243 1.7×	198 2.0×	18	931

Countries citing papers authored by Elsa M. Cora

Since Specialization

Citations

This map shows the geographic impact of Elsa M. Cora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elsa M. Cora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elsa M. Cora more than expected).

Fields of papers citing papers by Elsa M. Cora

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elsa M. Cora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elsa M. Cora. The network helps show where Elsa M. Cora may publish in the future.

Co-authorship network of co-authors of Elsa M. Cora

This figure shows the co-authorship network connecting the top 25 collaborators of Elsa M. Cora. A scholar is included among the top collaborators of Elsa M. Cora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elsa M. Cora. Elsa M. Cora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Cora, Elsa M., et al.. (2022). Expression of EGFR isoform D is regulated by HER receptor activators in breast cancer cells. Biochemistry and Biophysics Reports. 31. 101326–101326. 2 indexed citations

Wilken, Jason A., Marianela Pérez-Torres, René Nieves-Alicea, et al.. (2013). Shedding of Soluble Epidermal Growth Factor Receptor (sEGFR) Is Mediated by a Metalloprotease/Fibronectin/Integrin Axis and Inhibited by Cetuximab. Biochemistry. 52(26). 4531–4540. 22 indexed citations

Cristofanilli, Massimo, Vicente Valero, Aroop Mangalik, et al.. (2010). Phase II, Randomized Trial to Compare Anastrozole Combined with Gefitinib or Placebo in Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer. Clinical Cancer Research. 16(6). 1904–1914. 134 indexed citations

Valle, Blanca L., et al.. (2010). Abstract 275: The shedding of epidermal growth factor receptor is mediated by MMP-2 or MMP-9 and stimulated by fibronectin in MDA-MB-468 cells. Cancer Research. 70(8_Supplement). 275–275. 1 indexed citations

Baron, Andre T., Jacqueline M. Lafky, Cecelia H. Boardman, et al.. (2009). Soluble Epidermal Growth Factor Receptor: A Biomarker of Epithelial Ovarian Cancer. Cancer treatment and research. 149. 189–202. 11 indexed citations

Pérez-Torres, Marianela, et al.. (2008). Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells. Experimental Cell Research. 314(16). 2907–2918. 56 indexed citations

Iloro, Ibón, et al.. (2008). The Kinetics of the Hydrogen/Deuterium Exchange of Epidermal Growth Factor Receptor Ligands. Biophysical Journal. 94(10). 4041–4055. 8 indexed citations

Lafky, Jacqueline M., Andre T. Baron, Elsa M. Cora, et al.. (2005). Serum Soluble Epidermal Growth Factor Receptor Concentrations Decrease in Postmenopausal Metastatic Breast Cancer Patients Treated with Letrozole. Cancer Research. 65(8). 3059–3062. 24 indexed citations

Baron, Andre T., Elsa M. Cora, Jacqueline M. Lafky, et al.. (2003). Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.. PubMed. 12(2). 103–13. 82 indexed citations

10.

Maihle, Nita J., Andre T. Baron, Brigitte A. Barrette, et al.. (2002). EGF/ErbB Receptor Family in Ovarian Cancer. PubMed. 107. 247–258. 98 indexed citations

11.

Maihle, Nita J., Jacqueline M. Lafky, Andre T. Baron, et al.. (2002). EGF receptor/ErbB isoforms as serum biomarkers in breast and ovarian cancer. 25(1). 57–60. 3 indexed citations

12.

Cora, Elsa M. & Agnes B. Kane. (1991). Expression of the tumor suppressor gene, p53, during the development of murine malignant mesotheliomas induced by asbestos fibers. 2 indexed citations

13.

Little, S F, S H Leppla, & Elsa M. Cora. (1988). Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin. Infection and Immunity. 56(7). 1807–1813. 145 indexed citations

14.

Little, Stephen F., Stephen H. Leppla, & Elsa M. Cora. (1988). Production and Characterization of Monoclonal Antibodies Against the Protective Antigen Component of Bacillus anthracis Toxin. Defense Technical Information Center (DTIC). 1 indexed citations

15.

Cora, Elsa M., et al.. (1981). Role of High-Fat Diet in Tumorigenesis in C57BL/1 Mice<xref ref-type="fn" rid="fn2">2</xref><xref ref-type="fn" rid="fn3">3</xref><xref ref-type="fn" rid="fn4">4</xref>. JNCI Journal of the National Cancer Institute. 66(2). 297–301. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact